Hilco Redevelopment Partners (HRP), the real estate redevelopment unit of Hilco Global announced that the company has named Andrew Chused as Chief Investment Officer (CIO).

Chused, a co-founder of the HRP platform, previously served as Head of Investments. He played a leading role in transformational transactions for the company, including the acquisition of the former Sparrows Point steel mill, now Tradepoint Atlantic, in Baltimore; the ongoing redevelopment of L Street Station in Boston and the ongoing transformation of the former PES refinery, now The Bellwether District, in Philadelphia. As CIO, Chused will chart a course for HRP's long-term investment and portfolio-building plan while remaining essential to HRP's overall strategy around acquisitions, leasing, capital relationships and personnel.

Chused's promotion formalizes a senior leadership team that includes co-founder Ben Spera, who was named Chief Operating Officer (COO) in 2021. As COO, Spera leads on all aspects of HRP management, including corporate strategy and execution, overseeing budgets and personnel, and ensuring operational excellence, in addition to maintaining an active role in deal execution across the portfolio.

"At HRP, we are setting new industry standards by focusing on people, our communities and our environment, rather than simply buying property," said HRP CEO Roberto Perez. "Ben and Andrew have been integral to HRP's incredible progress to date, and they both embody the vision, passion and grit that it takes to move these transformational projects forward. We are building a team of leaders at HRP that are redefining what sustainable development looks like, and we're just getting started."

2022 marked a year of major milestones for HRP, including the completion of over 90% of demolition on The Bellwether District's 1,300-acre site, the granting of final approval for the first phase of the L Street Station redevelopment by the Boston Planning & Development Agency (BPDA), the leasing of over 1.35 million square feet across the HRP portfolio, and the successful $578 million sale of HRP's Centerpoint and The Gauge life sciences redevelopments in Waltham, Mass.